Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90,634 | 69,234 | 58,868 | 172,517 | 71,181 |
| Marketable Securities | 202,032 | 369,095 | 409,044 | 444,384 | 552,630 |
| Receivables | 165,491 | 114,585 | 105,555 | 114,717 | 110,725 |
| Inventories | 128,769 | 149,612 | 157,937 | 111,117 | 68,551 |
| TOTAL | $618,143 | $724,491 | $747,989 | $849,976 | $811,520 |
| Non-Current Assets | |||||
| PPE Net | 83,580 | 78,150 | 76,542 | 68,552 | 50,386 |
| Investments And Advances | 60,351 | 74,545 | 0 | 0 | 0 |
| Other Non-Current Assets | 119,038 | 90,472 | 128,127 | 134,257 | 43,231 |
| TOTAL | $262,969 | $243,167 | $204,669 | $202,809 | $93,617 |
| Total Assets | $881,112 | $967,658 | $952,658 | $1,052,785 | $905,137 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 47,067 | 44,730 | 49,586 | 55,730 | 28,032 |
| Accrued Expenses | 21,012 | 18,170 | 12,726 | 9,595 | 9,419 |
| Other current liabilities | 75,237 | 49,312 | 28,462 | 29,325 | 23,388 |
| TOTAL | $242,724 | $247,049 | $195,258 | $165,290 | $131,856 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9,527 | 11,831 | 43,994 | 18,837 | 10,182 |
| Other Non-Current Liabilities | 474,744 | 447,056 | 430,437 | 430,674 | 323,229 |
| TOTAL | $483,218 | $457,511 | $443,768 | $447,548 | $340,169 |
| Total Liabilities | $725,942 | $704,560 | $639,026 | $612,838 | $472,025 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,326 | 66,473 | 65,631 | 64,528 | 63,872 |
| Common Shares | 68 | 66 | 66 | 65 | 64 |
| Retained earnings | -1,252,535 | -1,047,825 | -951,800 | -729,189 | -634,595 |
| Other shareholders' equity | 5,593 | -1,947 | 1,369 | -1,817 | -616 |
| TOTAL | $155,170 | $263,098 | $313,632 | $439,947 | $433,112 |
| Total Liabilities And Equity | $881,112 | $967,658 | $952,658 | $1,052,785 | $905,137 |